Can integrative biomarker approaches improve prediction of platinum and PARP inhibitor response in ovarian cancer?
Ionut-Gabriel Funingana, Marika Reinius, Angelica Petrillo, Joo Ern Ang, James D. Brenton
Topics & Concepts
Ovarian cancerBiomarkerClinical PracticeOncologyBiomarker discoveryOvarian carcinomaInternal medicinePrecision medicineMedicineBioinformaticsCancerComputational biologyBiologyPathologyProteomicsGeneBiochemistryFamily medicineOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyCancer Genomics and Diagnostics